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Abstract 
The interest in perivascular cells as a niche for adult hematopoietic stem cells (HSCs) is 
significantly growing. In the adult bone marrow (BM), perivascular cells and HSCs 
cohabit. Among perivascular cells, pericytes are precursors of mesenchymal 
stem/stromal cells (MSCs) that are capable of differentiating into osteoblasts, adipocytes 
and chondrocytes. In situ, pericytes are recognised by their localisation to the abluminal 
side of the blood vessel wall, closely associated with endothelial cells in combination with 
the expression of markers such as CD146, neural glial 2 (NG2), platelet derived growth 
factor receptor β (PDGFRβ), α-smooth muscle actin (α-SMA), nestin (Nes) and/or leptin 
receptor (LepR). However, not all pericytes share a common phenotype: different 
immunophenotypes can be associated with distinct mesenchymal features, including 
hematopoietic support. In adult BM, arteriolar and sinusoidal pericytes control HSC 
behaviour, maintenance, quiescence and trafficking through paracrine effects. Different 
groups identified and characterized hematopoietic supportive pericyte subpopulations 
using various markers and mouse models. In this review, we summarize recent work 
performed by others to understand the role of the perivascular niche in the biology of 
HSCs in adults, as well as their importance in the development of therapies.  
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ABBREVIATIONS  
α Smooth Muscle Actin (α-SMA) 
Acute Myeloid Leukaemia (AML)  
Adventitial Reticular Cells (ARC) 
Bone Marrow (BM) 
Colony forming unit-fibroblasts (CFU-F) 
C-X-C Motif Chemokine Ligand 12 (Cxcl12) 
Cxcl12-abundant reticular (CAR) cells 
Diphtheria toxin receptor (DTR) 
Fluorescent activated cell sorting (FACS) 
Hematopoietic stem cells (HSCs) 
Hematopoietic stem/progenitor cell (HSPCs) 
Leptin Receptor (LepR) 
Mesenchymal stem/stromal cells (MSCs) 
Nestin (Nes) 
Neural glial 2 (NG2) 
Perivascular Cells (PVCs) 
Platelet derived growth factor Receptor (PDGFR) 
Stem cell factor (Scf) 
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1. INTRODUCTION 
Adult hematopoietic stem cells (HSCs) are a rare subpopulation of cells residing in 
the bone marrow (BM) with a well-defined phenotype, multi-lineage developmental 
potential, the capacity to reconstitute irradiated host recipients over the long-term in vivo, 
and the capacity to self-renew as shown by serial transplantations  (Kaimakis et al., 2013; 
Bhattacharya et al., 2016). In healthy subjects, HSC maintenance, behaviour and 
trafficking is largely dependent upon information they receive from the surrounding 
microenvironment or niche in which they are embedded. The concept of the niche was 
initially suggested after the work of Schofield in 1978 (Schofield, 1978) and has been 
defined as a small functional compartment with a specific anatomical position within an 
organ that homes and regulates stem cell activity, quiescence, self-renewal and 
differentiation for healthy tissue maintenance and repair (Mercier et al., 2012; Scadden, 
2006; Watt & Hogan, 2000).  
The hematopoietic niche of the BM is very complex and highly heterogeneous. It 
includes non-hematopoietic cell types such as osteoblasts, endothelial cells, pericytes, 
adipocytes, Schwann cells and nerves, and other hematopoietic cell types such as 
macrophages, osteoclasts, megakaryocytes, lymphocytes and neutrophils (Birbrair & 
Frenette, 2016). Recently, the putative existence of several niches for distinct 
haematopoietic outputs has been suggested (Mercier et al., 2012), due to variations in 
the composition and location of the immediate niche. Understanding how the different 
cell types are involved in the haematopoietic niches and whether and how the niches 
interact with each other and with HSCs is key to understand how the HSCs are regulated 
in homeostasis and hence, how they can be controlled in disease.  
Mesenchymal stem/stromal cells (MSCs) were first described by Friedenstein 
(Friedenstein et al., 1978) and coined later on by Caplan in 1991 (Caplan, 1991).  MSCs 
support haematopoietic stem cells in long term cultures in vitro via cell contact and 
secreted factors (Gottschling et al., 2007; Sorrentino et al., 2008; Van Overstraeten-
Schlogel et al., 2015), and enable HSC engraftment and repopulation when co-
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transplanted in both murine recipients and human patients (Battiwalla & Hematti, 2009; 
Jui et al., 2012; Le Blanc et al., 2007). However, MSCs were only characterised in culture 
retrospectively using the minimal criteria defined by the International Society for Cellular 
Therapy in 2006: MSCs adhere to plastic culture dishes, express CD90, CD105, CD73 
and CD44, do not express endothelial and hematopoietic markers CD45, CD34, CD14, 
CD11b, CD79α, CD19 and HLA-DR, and differentiate in vitro into osteoblasts, adipocytes 
and chondrocytes (Dominici et al., 2006). Nevertheless MSCs remain heterogeneous 
and thus interest in prospectively isolating them directly from organs before culture has 
been continuously growing. Common mesenchymal/stromal markers associated with 
haematopoiesis are Stro-1, CD271, CD146, stem cell factor (Scf), Nestin (Nes), Sca-1, 
C-X-C motif chemokine ligand 12 (CXCL12), Leptin Receptor (LepR), Alkaline 
Phosphatase and CD105 (Flores-Figueroa et al., 2012). Importantly, recent studies have 
demonstrated that in vivo, such MSCs reside in the perivascular wall of the blood vessels 
in multiple organs (Corselli et al., 2012; Crisan et al., 2008; Murray et al., 2014) and are 
actively present in the haematopoietic niche (Birbrair & Frenette, 2016; Morrison & 
Scadden, 2014).  
This review focuses on the role of different subsets of pericytes found to be integral 
components of adult haematopoietic stem cell niches, and highlights their importance as 
targets in developing new strategies to control disease progression.   
 
2. PERICYTES, PRECURSORS OF MESENCHYMAL STEM/STROMAL CELLS 
2.1. Definition 
Pericytes are perivascular stellate cells that form a discontinuous layer in close 
contact with the endothelial cells surrounding capillaries and a continuous layer around 
microvessels (Diaz-Flores et al., 1991). They were first described as Rouget cells by 
Charles Marie Rouget (Rouget, 1873), but were renamed in 1923 by Zimmermann, as 
pericytes (Zimmermann, 1923). Early studies suggested vascular support as the major 
role of pericytes through direct cell contact and cell communication via specific junctions. 
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They are contractile and regulate vessel diameter (Gerhardt & Betsholtz, 2003) and 
maintain blood vessel integrity and permeability (Stallcup et al., 2016).  More recently, 
stem cell properties have been associated with pericytes.  
 
2.2 Pericytes share similar features with mesenchymal stem/stromal cells 
Perivascular cells gained further interest when they were described to be bona 
fide MSCs. Present in virtually all vascularized organs, pericytes adhere to plastic culture 
dish, express MSCs markers CD90, CD44, CD105 and CD73 before and after culture 
and have adipogenic, osteogenic and chondrogenic potentials, cardinal properties of 
MSCs (Crisan et al., 2008; Crisan et al., 2011; Doherty et al., 1998; Farrington-Rock et 
al., 2004; Lin et al., 2008; Pierantozzi et al., 2015; Zimmerlin et al., 2014).  
Recent studies have investigated pericyte involvement in bone and cartilage 
formation and regeneration, cardiac regeneration, brain vasculature, cancer 
angiogenesis, immunomodulation and hematopoietic support. Pericytes from multiple 
human organs regenerate damaged muscle fibres in different mouse models (Crisan et 
al., 2008; Dellavalle et al., 2011; Park et al., 2011) and improve cardiac function when 
injected into myocardial infarcted heart (Chen et al., 2013). However, cardiac derived 
pericytes are unable to differentiate into skeletal muscle fibres although they can 
differentiate into other mesodermal lineages – adipocytes, osteoblasts and 
chondrocytes- suggesting the existence of heterogeneity between pericytes from 
different organs (Chen et al., 2015). Pericytes derived from skeletal muscle, adipose 
tissue or BM successfully mineralise or regenerate the broken bone in vivo (Crisan et al., 
2008; James et al., 2012a; James et al., 2012b; Sacchetti et al., 2007; Sacchetti et al., 
2016). Importantly, pericytes associated with small vessels of the bone marrow and white 
adipose tissue, have been shown to support hematopoiesis in vitro and in vivo (Birbrair 
& Frenette, 2016; Corselli et al., 2013; Morrison & Scadden, 2014). Additionally, another 
perivascular cell type, adventitial pericytes, located in the adventitia layer of large blood 
vessels, was also described to display mesenchymal potential. CD34+CD31- adventitial 
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pericytes can differentiate into mesodermal lineages, especially contributing to 
angiogenesis (Campagnolo, 2010; Zengin, 2006), and are suggested to be pericyte 
progenitors (Howson, 2005; Corselli, 2012). 
In conclusion, pericytes are endowed with mesodermal differentiation potential 
when seeded in specific conditions in vivo and in vitro, and actively participate in the 
regeneration process under experimental conditions. It is important to understand their 
physiological roles in tissue development and homeostasis, and whether they directly 
participate in repair and regeneration processes.  Some studies have started to address 
this using cell lineage tracing experiments and have shown that pericytes can naturally 
generate and/or regenerate certain tissues (Bouacida et al., 2012; Dulauroy et al., 2012; 
Feng et al., 2011; Goritz et al., 2011; Kozanoglu et al., 2009; Krautler et al., 2012; Olson 
& Soriano, 2011; Tang et al., 2008; Zhao et al., 2014). However, pericytes are 
heterogeneous and may fall into functionally distinct groups based on their location and 
on the pathological state of the organ  (Birbrair et al., 2014a; Birbrair et al., 2014b; Birbrair 
et al., 2013a, Birbrair et al., 2013b; Birbrair et al., 2013c). Thus, clear identification and 
characterisation of different pericyte subsets in situ is necessary for further 
investigations. 
 
2.3 Markers of perivascular cells  
Most of the pericyte markers described so far in the literature are also present in other 
cell types. In addition, not all pericytes express the same markers. Therefore pericytes 
require a combination of markers for their proper characterisation. Here we summarize 
the most commonly used markers for pericytes in both human and mouse tissues. 
Also known as M-CAM or MUC18, CD146 adhesion molecule is a membrane 
glycoprotein (Shih, 1999) that plays a role in the interaction between endothelial cells 
and pericytes, by binding to laminin α4 (Ishikawa et al., 2014). The germline CD146 
knock-out mice are viable with no specific phenotype (Jouve et al., 2015). First identified 
in melanoma cells and associated with tumour metastasis and vascularization (Lehmann 
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et al., 1987), CD146 is also expressed by human pericytes and endothelial cells (Crisan 
et al., 2008; Sers, Riethmüller, & Johnson, 1994), smooth muscle cells (Sers et al., 1994; 
Tormin et al., 2011) and few T and B lymphocytes (Covas et al., 2008).  
Nestin (Nes)  is an intermediate filament protein type IV that binds to and 
regulates the assembly of intermediate filaments such as vimentin, desmin and 
internexin (Steinert et al., 1999). Germline deletion of nestin is embryonic lethal. Few  
mice survive and have impaired coordination suggesting a role in the neural system 
(Park et al., 2010). Indeed, nestin was described as a neural stem cell maker (Birbrair et 
al., 2013b; Lendahl, Zimmerman, & McKay, 1990) and was also detected in pericytes in 
the brain, skeletal muscle and BM (Alliot et al., 1999; Birbrair et al., 2013b; Mendez-
Ferrer et al., 2010). Subsequently, nestin has also been described in cancer cells 
(Krupkova et al., 2010), myofibroblasts (Kishaba et al., 2010) and endothelial cells 
(Mokry et al., 2004; Suzuki et al., 2010). Not all pericytes express nestin. Pericytes of 
the blood vessels in the rat testis only express it transiently during the regeneration of 
chemoablated Leydig cells (Davidoff et al., 2004).  
Leptin Receptor (LepR) also known as CD295 and OB-R, is a type I 
transmembrane glycoprotein class I cytokine receptor (Zhang et al., 1997). The ligand of 
LepR is leptin, an adipocyte-derived hormone firstly associated to lipid metabolism and 
obesity (Coleman, 1978). Germline LepR knock out mice are obese with hyperglycemia, 
glucose intolerance and elevated levels of insulin (Wang, Chandrasekera, & Pippin, 
2014). Leptin/LepR signalling was shown to be involved in immune homeostasis, 
reproduction, haematopoiesis, angiogenesis and haematological malignancies (Han & 
Wang, 2015; Konopleva et al., 1999) and bone formation (Chen & Yang, 2015).  In 
addition, LepR is expressed in pericytes surrounding sinusoids in the mouse BM and 
microvessels in human adipose tissue (Corselli et al., 2013; Ding et al.,  2012; Zhou et 
al., 2014).  
Other markers expressed by pericytes are neural glial antigen 2 (NG2), platelet 
derived growth factor receptors (PDGFRα, PDGFRβ) and α-smooth muscle actin 
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(αSMA). NG2, also known as chondroitin sulphate proteoglycan 4, plays a role in cell 
proliferation and migration during vasculogenesis, and binding to collagen α2 and β1 
integrin (Stallcup & Huang, 2008).  NG2 knock-out mice are not lethal and do not have 
an apparent phenotype (Grako et al, 1999). However, under a high fat diet, NG2 knock-
out mice become obese and have fatty livers (Chang et al., 2012). Moreover, the 
permeability of the blood vessels increases with a decrease in pericyte coverage 
(Stallcup et al., 2016). This is in line with NG2 expression in pericytes of the arterial 
system (Crisan et al., 2009; Murfee et al, 2005). NG2 is also expressed on macrophages, 
glial cells and various tumour cells (Murfee et al., 2006). PDGFRα is a cell surface 
tyrosine kinase that interacts with PDGFA, PDGFB, integrin β3, caveolin-1 and nexin 
among other molecules (Ricono et al., 2009; Morikawa et al., 2009). PDGFRβ plays a 
key role during capillary sprouting recruiting pericytes via PDGFB/PDGFRβ signalling 
(Hellstrom et al., 1999; Stapor et al, 2014; Lindahl et al., 1997). PDGFRβ is also 
expressed on smooth muscle cells, interstitial fibroblast and glial cells (Bonner, 2004; 
Robbins et al., 1994). α-SMA is expressed in pericytes, smooth muscle cells and 
myofibroblasts (Cherng et al., 2008).  Smooth muscle actin plays a role in cell motility 
and vessel integrity (Nehls & Drenckhahn, 1991). Not all pericytes express α-SMA and 
together with NG2, can be used to discriminate subsets of pericytes such as pericytes 
associated with arterioles (NG2+α-SMA+), capillaries (NG2+α-SMA-) and venules (NG2-
α-SMA+) (Nehls & Drenckhahn, 1991; Crisan et al., 2008, 2009). 
In summary, pericytes express different markers that may vary between species, 
tissues or developmental stage. This phenotypic heterogeneity suggests that pericytes 
surrounding distinct blood vessel types may also play different functions.  
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3.  PERICYTES, INTEGRAL COMPONENTS OF THE ADULT HEMATOPOIETIC 
STEM CELL NICHES  
In the past, MSCs have increasingly been implicated in HSC support as major 
components of the HSC niche (Kfoury & Scadden, 2015). As pericytes were shown to 
be a reservoir of MSCs in vivo and in addition, proximal to HSCs, recent studies have 
focused on their role in HSC regulation. The BM is located in the bone cavity which is 
highly vascularised especially enriched in arterioles, thin-wall innervated vessels 
surrounded by smooth muscle cells, and sinusoids, more evenly distributed, larger and 
fenestrated that allows cell trafficking between the BM and the blood stream (Hooper et 
al., 2009; Itkin et al., 2016; Khan et al., 2016; Kunisaki et al., 2013). Both arteriolar and 
sinusoidal pericyte populations have been recently studied as part of the hematopoietic 
niches using distinct marker expression as for example CD146, Nes and LepR (Figure).  
 
3.1 CD146 perivascular cells support the adult hematopoietic stem cells 
In human adult BM, CD146 expression is found near sinusoids in subendothelial 
cells, also called adventitial reticular cells (ARCs). In 2007, the group of Paolo Bianco 
demonstrated that CD146+ ARCs are key players in the niche of HSCs (Sacchetti et al., 
2007). In this study, they showed that CD146+ cells express known mesenchymal 
markers e.g. CD105, CD63, alkaline phosphatase, among others, and have the ability to 
form colony-forming unit-fibroblasts (CFU-F). They are in contact with endothelial cells 
and they express other pericyte markers such as αSMA, NG2 and PDGFRβ, and are 
negative for hematopoietic and endothelial markers (CD45, CD34 and CD31) (Sacchetti 
et al., 2007). Interestingly, when transplanted into immunodeficient mice, CD146+ cells 
formed ossicles composed of donor derived bone and sinusoids in combination with host 
derived endothelium and hematopoietic cells demonstrating the ability of these 
prospectively purified cells to support haematopoiesis in vivo. Not all single CD146+ 
clones were able to generate heterotopic ossicles following transplantation, suggesting 
that the CD146+ population is heterogeneous or changes in culture. Indeed, in hypoxic 
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conditions, CD146 is downregulated in culture (Tormin et al., 2011). Furthermore, 
CD146-/low cells of the trabecular bone or periosteum are also able to form bone upon 
transplantation, but do not transfer the hematopoietic microenvironment, suggesting that 
not all bone progenitors support HSCs in vivo (Sacchetti et al., 2007).  Cultured CD146+ 
cells highly express osteogenic progenitor transcripts (COL1A1, COL1A2, RUNX2, etc.) 
and HSC niche related transcripts, such as Jagged-1 (Notch ligand), N-Cadherin, 
CXCL12 and the KIT ligand (SCF) (Sacchetti et al., 2007). These molecules have been 
implicated in the maintenance of HSCs in the mouse BM in vitro and in vivo (Duncan et 
al., 2005, Sugiyama et al., 2006, Wilson & Trumpp, 2006).  
 In addition to BM, CD146+ pericytes purified from the human adult white adipose 
tissue are also able to support hematopoietic stem/progenitor cells (HSPCs) ex vivo 
(Corselli et al., 2013). This is not a surprise. In the mouse, white adipose tissue contains 
a population of immature HSCs that have a transcriptional profile very similar to BM 
HSCs (Poglio et al., 2012). A previous study showed that transplantation of the stromal 
vascular fraction (SVF) derived from murine adipose tissue containing stromal cells, 
adipocyte progenitors and hematopoietic progenitors (CD45+CD34+) into lethally 
irradiated immunodeficient mice, was able to rescue the host hematopoietic system 
(Cousin et al., 2003), suggesting that white adipose tissue contains stromal cells with 
hematopoietic supportive ability. Corselli et al. demonstrated that only the CD146+ cell 
population supports HSC activity in co-culture experiments with human cord blood 
hematopoietic stem cells, which is in line with Sacchetti et al. observations (2007). 
Primary immunodeficient recipients were engrafted at long-term when injected with 
CD45+ donor hematopoietic cells from CD146+co-cultures and could further repopulate 
secondary recipients. CD146+cells were able to activate Notch signalling in HSPCs 
(Corselli et al., 2013), in agreement with previous reports suggesting that Notch 
signalling regulates the growth and differentiation of HSPCs via the microenvironment 
(Bigas et al., 2010). Interestingly, CD146+ pericytes from the fetal BM and adult adipose 
tissue co-express Nestin, CXCL-12 and LepR, markers that have previously been used 
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to define pericytes with HSC niche activity in the murine BM (Ding et al., 2012; Mendez-
Ferrer et al., 2010; Sugiyama et al., 2006). In conclusion, CD146+ perivascular cells 
support HSCs. 
 
3.2 Nestin-expressing pericytes support hematopoietic stem cells and are highly 
heterogeneous 
Pericytes expressing nestin (Nestin+CD31-CD34-VE-Cadherin-CD45-) were 
identified and described in the BM of Nestin-GFP mice (Mendez-Ferrer et al., 2010). 
These cells were found within the BM parenchyma and in regions adjacent to the bone. 
Nes-GFP+ (Nes+) cells highly express HSC maintenance related genes such as Cxcl12, 
Adrb3 and Angiopoietin-1, and can be cultured as mesenspheres in non-adherent 
cultures that self-renew and differentiate into osteoblasts, adipocytes and chondrocytes 
(Mendez-Ferrer et al., 2010). In vivo, serial transplantations revealed that Nes+ pericytes 
generate ectopic bone, self-renew and support hematopoiesis (Mendez-Ferrer et al., 
2010).  Similar to the mouse, human fetal and adult BM also contain a similar population 
of Nes+ cells. However, this population is heterogeneous and can be further separated 
on the expression of CD105 (Isern et al., 2013), a cell surface marker of osteoprogenitor 
cells (Aslan et al., 2006). Furthermore, all CFU-F and sphere-forming capacities were 
observed in CD105+CD146+ cells but not in CD105+CD146- nor CD105-CD146- cells 
(Isern et al., 2013), in line with previous reports (Sacchetti et al., 2007; Tormin et al., 
2011). In addition, CD34+ human cord blood-derived hematopoietic cells expanded when 
co-cultured with these mesenspheres, were multilineage and serially engrafted 
immunodeficient recipients in transplantation assays suggesting that at least a subset of 
human Nes+ cells also support HSCs (Isern et al., 2013).  
To test the in vivo requirement of murine Nes+ cells in HSC maintenance, 
Mendez-Ferrer et al., (2010) further crossed a Cre-inducible diphteria toxin receptor 
(iDTR) mouse line with Nes-creERT2 mice. This model enables the selective deletion of 
Nes-creERT2 cells upon diphtheria toxin injection. Ablation of these cells led to a decrease 
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in the BM HSC number mainly due to their reduced homing abilities, suggesting that 
Nes+ pericytes are involved in the regulation of HSC traffic. HSC number was 
proportionally increased in the spleen, but whether the HSCs found in the spleen were 
proximal to pericytes was not shown.  
Another Nes+ pericyte subset with MSC activity in the mouse BM was further 
identified (Pinho et al., 2013). Nes+CD51+PDGFRα+ triple positive cells show higher 
levels of Cxcl12, Vcam1, Angpt1, Scf and Opn, all HSC regulatory genes, compared to 
the Nes+CD51-PDGFRα-, Nes+CD51+PDGFRα- and Nes+CD51-PDGFRα+ populations. 
These populations were clonally expanded as mesenspheres, and single spheres were 
implanted into ectopic grafts. Only triple positive cells were able to self-renew and 
transfer the hematopoietic microenvironment (Pinho et al., 2013). These cells largely 
overlap with LepR+ perivascular cells, which are a major producer of SCF in the murine 
BM (Ding et al., 2012). Conditional deletion of Scf in Nes+ cells (Nes-cre/Scffl/- or Nes-
creER/Scffl/- ) did not reduce HSC frequency in the BM, but instead, it induced a 
significant decline in HSCs in the spleen, suggesting that Nes+ cells are also a 
component of the HSC niche in the spleen (Ding et al., 2012).  
The maintenance of HSC numbers in Nes-cre/Scffl/- mice or Nes-creER/Scffl/- is in 
line with the lack of nestin expression found in Scf-GFP cells: while Nes-GFP+ cells 
showed the same distribution as Scf-GFP+ cells, Cherry+ cells from Nes-Cherry/Nes-
GFP double transgenic mice, as well as EYFP+ cells from recombined Nes-cre/loxP-
EYFP mice were only detected around large blood vessels in bone cryosections (Ding 
et al., 2012). In situ characterization of Nes+ cells in the BM of wild-type mice will therefore 
be necessary to better understand and clarify the role of Nes+ pericytes in the 
maintenance of HSCs in the BM. 
Nes+ cells occupying a perivascular position were confirmed in human fetal and 
adult BM (Ferraro et al., 2011; Pinho et al., 2013). In the fetal BM Nes+PDGFRα+CD51+ 
cells were detected in close contact with αSMA vasculature and HSPCs, and expression 
of high levels of HSC maintenance genes (Cxcl12, Vcam1, Angpt1, Opn and Scf) was 
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detected between 15 and 20 weeks of gestation. Interestingly, CD146 was 
homogeneously expressed in these cells, but only a small fraction of CD146+pericytes 
expressed nestin, PDGFRα and CD51. This fraction was enriched in HSC niche 
transcripts and CFU-F activity compared to non-triple positive cells (Pinho et al., 2013), 
suggesting that the CD146+ pericytes previously described in human tissues are 
heterogeneous (Corselli et al., 2013; Sacchetti et al., 2007). Transplantations of human 
CD51+PDGFRα+ cells isolated from fetal BM into immunodeficient mice also led to the 
formation of HSC ectopic niche which recruited host HSCs to the grafts. In addition, 
mesenspheres cultured from this same population were able to expand HSPCs ex vivo 
prior engraftment into recipient mice (Pinho et al., 2013).  
Kunisaki et al. further investigated the distribution of Nes-GFP in pericytes around 
arterioles and sinusoids based on transgene expression (Kunisaki et al., 2013). Nes-
GFPbright cells were rarer and found exclusively along arterioles in both sternal and long 
BM (Nesperi) while Nes-GFPdim were associated with sinusoids and displayed a more 
reticular shape (Nesretic) (Kunisaki et al., 2013). Although both subpopulations were 
capable of CFU-F formation, most colonies were formed from Nesperi cells. RNA 
sequencing data showed that the expression of HSC niche related genes Cxcl12, Scf, 
Angtp1, Vcam1 and Opn, was higher in Nesperi cells compared to Nesretic cells. Nesretic 
cells were found to largely overlap with the LepR+ pericytes (major SCF producers) 
described by Ding et al. (Ding et al., 2012), while no overlap was detected between 
Nesperi and LepR+ cells (Kunisaki et al., 2013). In addition, Nesperi but not Nesretic cells 
expressed the pericytic markers αSMA and NG2. NG2 expression in the BM was 
restricted to approximately 30% of Nesperi cells. Diphtheria toxin-induced depletion of 
NG2+cells in NG2-creERTM/iDTR recombined mice altered the localization of HSCs away 
from arterioles  suggesting a role in HSC quiescence and maintenance (Kunisaki et al., 
2013). In conclusion, nestin-expressing perivascular cells support HSCs and are highly 
heterogeneous. 
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3.3 Leptin Receptor- expressing cells secrete factors that are crucial for 
HSC maintenance 
In a study performed to unravel how Scf expressing cells affect HSC maintenance 
in the mouse BM, Ding et al. observed a LepR+ pericyte population that was restricted to 
Scf-GFP+ cells in the mouse BM sinusoids (Ding et al., 2012). Gene expression profiling 
of LepR+ pericytes showed expression of MSC genes such as Cxcl12, alkaline 
phosphatase, PDGFRα and PDGFRβ, with no nestin expression detected. Surprisingly, 
and in contrast with all the perivascular cell populations with MSC activity previously 
described, bone-lining cells from LepR-cre/loxP-EYFP mice did not express EYFP in 
situ, suggesting that LepR+ cells do not give rise to osteoblasts in vivo (Ding et al., 2012). 
Cxcl12 conditional deletion in LepR-cre;Cxcl12fl/- mice led to a reduction in the frequency 
of HSPCs in adult BM with an increase in their number in the circulation, suggesting a 
role for this chemokine in retaining HSCs in the BM niche (Ding & Morrison, 2013). 
Conditional deletion of Scf from Lepr-cre cells led to a reduction in HSC number in the 
BM, but not in the developing liver of newborns (Ding et al., 2012). Thus, LepR+ pericytes 
play an important role in HSC maintenance in the mouse BM. In human fetal BM and 
adipose tissue, immunofluorescence showed no differences in LepR expression 
between CD146+ and CD146- cultured cells (Corselli et al., 2013). It will be important to 
test whether similar results are observed in situ prior to culture, or if CD146- cells purified 
from these tissues upregulate LepR expression under the culture conditions used. Upon 
co-culture with CD146- cells, human cord blood derived CD34+ hematopoietic cells did 
not engraft primary recipient mice in vivo (Corselli et al., 2013) raising the question as to 
whether in these human tissues, LepR specifically marks HSC niche cells at least in 
culture. LepR+ pericytes were later shown to largely overlap with Nes-GFP+ pericytes in 
LepR-cre/LSL-tdtomato/Nes-GFP mice (~80% of the cells), and 63% with the 
Nes+CD51+PDGRα+ population (Pinho et al., 2013). In conclusion, LepR+ pericytes 
contribute to the niche of hematopoietic stem cells and overlap with other pericyte 
subsets described as integral part of the niche. 
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4. PERICYTES AS POTENTIAL TARGETS FOR THERAPY DEVELOPMENT  
Changes in the hematopoietic niche have been implicated in diseases, such as 
leukemia. It has been long known that the microenvironment is a key player in many 
primary tumours as well as in metastasis. Drug development using cancer cells without 
taking into account their surroundings has enabled the treatment of certain diseases, but 
has proven to be insufficient. The development of more efficient therapies should take 
into account cells that surround and support malignant cells, i.e. the tumour 
microenvironment  (McMillin et al., 2013).  
Stromal cells can influence the response of cancer cells to chemotherapy. For 
instance, certain leukemic cells are more resistant to chemotherapeutic agents in the 
presence of the BM stromal cells than when cultured alone (Moshaver et al., 2008; Polak 
et al., 2015; Zhang et al., 2012). Interestingly, the opposite effect (known as synthetic 
lethality) has also been described, in which tumour cells become more susceptible to 
drugs within a certain microenvironment (McMillin et al., 2010). This resistance or 
susceptibility implies that bidirectional communication between leukemic cells and their 
microenvironment exists (McMillin et al., 2013). For instance, acute myeloid leukemia 
(AML) was shown to alter the hematopoietic niche (Hanoun et al., 2014). AML leads to 
a reduction in NG2+ perivascular cell numbers and to denervation of arterioles. Due to 
the loss of catecholaminergic nerve fibres that are required to maintain the quiescence 
of MSCs (Mendez-Ferrer et al., 2008), Nes+ pericytes are expanded and become more 
committed to the osteoblastic lineage that supports leukaemia progression. In addition, 
HSC maintenance gene expression is greatly reduced in these cells, leading to depletion 
of healthy HSCs in the BM (Hanoun et al., 2014). Another study showed that 
myelodysplastic cells in patients were able to reprogram MSCs to establish a stem cell 
disease niche unit (Medyouf et al., 2014). In contrast, initial perturbation of mouse 
osteoprogenitors was also able to induce BM dysfunction and myelodysplasia 
suggesting that the tumour microenvironment also plays a key role in cancer initiation 
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and progression (Raaijmakers, 2011; Raaijmakers et al., 2010). Overall it is crucial that 
pre-clinical studies include cells that constitute the microenvironment in order to have a 
more realistic idea of the possible outcomes of treatments in vivo.  
Most studies focusing on the effects of the tumour microenvironment on cancer 
cells and their response to chemotherapy were performed using heterogeneous 
mesenchymal stromal cells. Understanding the mechanisms underlying drug resistance 
or sensitivity in more purified stromal cell populations, as well as how alterations to these 
cells are linked with disease is imperative for the development of novel and more precise 
treatments. Many chemotherapeutic agents target cycling cells, and therefore do not 
affect the most quiescent ones, which is one of the major causes of relapse. Pericytes in 
the BM niche were shown to maintain the quiescence of HSCs and protect them against 
genotoxic insults in the mouse (Kunisaki et al., 2013). In addition, depletion of these 
NG2+ cells activated HSC cycling and mobilization (Kunisaki et al., 2013). Targeting 
these pericytes in leukemic patients could be a potential way of overcoming the 
quiescence leukemic stem cells and thus decreasing the chance of relapse.   
Another important aspect to take into account when developing new strategies to 
treat tumours with high mortality rates is metastasis. A major driver of metastasis is 
angiogenesis. In cancer, the stable association between pericytes and endothelial cells 
is disrupted followed by changing in vascular permeability allowing cancer cells to enter 
the bloodstream. BM biopsies from patients with AML display enhanced angiogenesis at 
diagnosis. It was found that pericyte coverage is reduced compared to healthy BM. When 
remission is achieved, microvessel density is restored and pericyte counts increase 
(Weidenaar et al., 2011). Treatment with drugs that interfere with VEGF/VEGFR 
signalling were shown to induce a normalized vessel pattern and increase the pericyte 
coverage of the tumour blood vessels (Jain, 2005)(Jain, 2005). Another way to stimulate 
blood vessel coverage with pericytes was shown in hereditary haemorrhagic 
telangiectasia (HTT), where patients suffer from vascular malformations leading to 
frequent nosebleeds. Thalidomide was shown to reduce the severity and frequency of 
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the bleeding. In the mouse model for HTT, thalidomide treatment was shown to stimulate 
the pericyte coverage of blood vessels by increasing PDGFB expression in endothelial 
cells, which leads to the activation and recruitment of pericytes (Lebrin et al., 2010). 
Increased vascular permeability and decrease in HSC number in the bone marrow was 
also found in diabetes, in both patients and mouse models (Oikawa et al., 2010; Spinetti 
et al., 2013). Decrease in the density of microvessels including capillaries, sinusoids and 
arterioles, and functional alterations of endothelial cells were found. It would be thus 
important to investigate whether different pericyte subsets shown to have a role in the 
HSC niche are also affected.  We can speculate that, in diabetes, some of these pericytes 
change their behaviour and/or differentiate, thus losing their HSC supportive roles. 
Indeed, higher adipose tissue deposition was found in the bone marrow of the diabetic 
mice but also in patients with type 2 diabetes (Spinetti et al., 2013). This may secondarily 
influence the cell cycle status of HSCs together with their mobilisation into the 
bloodstream or their survival as previously suggested (Mangialardi et al., 2014).  
 
 
5. CONCLUSIONS 
We have here reviewed the concept that within the perivascular component, 
different subtypes of HSC supportive cells exist. We know that these subtypes are 
distinct and to some degree overlapping (Figure, Table). However, some discrepancies 
exist between studies. This may be due to the technical approach, e.g. the experimental 
conditions employed, the mouse models used, or the recombination efficiency. For 
instance, Nes-GFP+ cells from Nes-GFP mice show a very different distribution when 
compared to Nes-cre and Nes-creER cells, and, depending on the model, play distinct 
roles on HSC maintenance (Ding et al., 2012; Mendez-Ferrer et al., 2010). In addition, a 
perivascular cell population called CXCL12-abundant reticular (CAR) cells, has been 
described in a peri-sinusoidal position in CXCL12-GFP and CXCL12-DTR-GFP mice 
(Omatsu et al., 2010; Sugiyama et al., 2006). The number of HSCs as well as lymphoid 
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and myeloid progenitors were reduced two days after CAR cells were depleted upon 
diphtheria toxin injection. The remaining HSCs were more quiescent suggesting that 
CAR cells influence HSC activation in the mouse BM. Whether CAR cells overlap with 
Nes+ or LepR+ supportive pericytes remains unclear (Table).   
Additionally, BM is highly complex and a variety of other niche components are 
involved in HSC support in addition to the perivascular cells. Whether and how these 
components interact with each other to regulate HSCs remains to be investigated.  As 
the microenvironment is expected to maintain tissue homeostasis, it is reasonable to 
think that compensatory mechanisms take place when the niche is altered, as for 
example when a specific cell type is depleted. Studying all niche components 
simultaneously is challenging and to date none of the existing mouse models can be 
used to face this complexity. Currents models only allow study of perivascular cell 
subsets individually and thus studies should qualify their conclusions until further 
research should bring clarifications. Given that pericytes are involved in such a variety 
of pathologies, overcoming these technical limitations will allow a better understanding 
of their function in homeostasis and disease, and pave way for novel therapies.   
More questions remain unanswered. Recent studies have shown that there are 
more than one type or subtype of HSCs in the BM (Benz et al., 2012; Challen et al., 
2010; Crisan et al., 2015). Some are controlled by bone morphogenic protein (BMP) and 
others are regulated by the transforming growth factor β (TGFβ) signalling pathway. It is 
crucial to address whether these types or subtypes are proximal to a particular niche for 
a better understanding of the development of specific types of leukaemia and other 
diseases. 
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Legend to Figure: schematic representation of the described bone marrow 
perivascular cell populations controlling adult hematopoietic stem cell (HSC) 
activity. 
Human bone marrow is located within the trabecular region of the large bones, highly 
vascularised and rich in microvessels and capillaries. Different subtypes of pericytes 
were described to support HSCs in the bone marrow.  Pericyte subsets from independent 
studies are shown separately. This representation does not imply that these subsets are 
necessarily distinct, some being shown to overlap (see Table).  In human bone marrow, 
(A) niche supportive CD146+ pericytes expressing CXCL12, JAGGED-1, ANGPT-1 and 
SCF are present surrounding sinusoids.  In murine bone marrow, (B) quiescent HSCs 
can be located close to arterioles and are regulated by Nes+ and NesperiNG2+ pericyte 
subset; (C) CXCL12-abundant reticular (CAR) cells, located around sinusoids promote 
HSC activation and express CXCL12, JAGGED-1 and SCF; (D) perisinusoidal Leptin 
Receptor (LepR+) and Nes+ pericytes promote HSC quiescence and express SCF and 
CXCL12 respectively. Only tested protein expression is shown. 
 
